Home Applications 021473 Application 021473
Type NDA
Sponsor BAYER HLTHCARE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CIPRO XR CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 212.6MG;EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** No No 002 CIPRO XR CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 425.2MG;EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021473-001 CIPRO XR CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE 212.6MG;EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2002-12-13 N021473-002 CIPRO XR CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE 425.2MG;EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2003-08-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N021473-001 CIPRO XR 212.6MG;EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2002-12-13 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N021473-002 CIPRO XR 425.2MG;EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2003-08-28 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021473-001 CIPRO XR 212.6MG;EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2002-12-13 e64feba35796…2022-09-29 23:25 UTC 2022-09 N021473-002 CIPRO XR 425.2MG;EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2003-08-28 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021473-001 CIPRO XR 212.6MG;EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2002-12-13 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021473-002 CIPRO XR 425.2MG;EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2003-08-28 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021473-001 CIPRO XR 212.6MG;EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2002-12-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021473-002 CIPRO XR 425.2MG;EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET, EXTENDED RELEASE / ORAL 2003-08-28 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 72 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021473-001 7709022 2021-06-23 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021473-001 8187632 2021-06-23 Drug product 2013-06-20 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021473-001 7709022*PED 2021-12-23 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021473-001 8187632*PED 2021-12-23 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021473-002 7709022 2021-06-23 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021473-002 8187632 2021-06-23 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021473-002 7709022*PED 2021-12-23 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021473-002 8187632*PED 2021-12-23 Pediatric extension 74a2ff9319b5…2021-12-28 21:50 UTC 2021-12 N021473-001 7709022 2021-06-23 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021473-001 8187632 2021-06-23 Drug product 2013-06-20 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021473-001 7709022*PED 2021-12-23 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021473-001 8187632*PED 2021-12-23 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021473-002 7709022 2021-06-23 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021473-002 8187632 2021-06-23 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021473-002 7709022*PED 2021-12-23 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021473-002 8187632*PED 2021-12-23 Pediatric extension 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-001 7709022 2021-06-23 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-001 8187632 2021-06-23 Drug product 2013-06-20 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-001 7709022*PED 2021-12-23 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-001 8187632*PED 2021-12-23 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-002 7709022 2021-06-23 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-002 8187632 2021-06-23 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-002 7709022*PED 2021-12-23 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021473-002 8187632*PED 2021-12-23 Pediatric extension 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021473-001 7709022 2021-06-23 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021473-001 8187632 2021-06-23 Drug product 2013-06-20 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021473-001 7709022*PED 2021-12-23 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021473-001 8187632*PED 2021-12-23 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021473-002 7709022 2021-06-23 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021473-002 8187632 2021-06-23 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021473-002 7709022*PED 2021-12-23 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021473-002 8187632*PED 2021-12-23 Pediatric extension 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021473-001 7709022 2021-06-23 Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021473-001 8187632 2021-06-23 Drug product 2013-06-20 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021473-001 7709022*PED 2021-12-23 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021473-001 8187632*PED 2021-12-23 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021473-002 7709022 2021-06-23 Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021473-002 8187632 2021-06-23 Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021473-002 7709022*PED 2021-12-23 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021473-002 8187632*PED 2021-12-23 Pediatric extension 8869cabd3fbd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 2 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 50419-788 Cipro ciprofloxacin Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-789 Cipro ciprofloxacin Bayer HealthCare Pharmaceuticals Inc. NDA Current